Coronavirus disease (COVID-19) technical guidance by WHO Laboratory testing for COVID-19 | Page 7

Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases
Acknowledgements
The following people contributed to the drafting of
the evolving versions of this guidance document:
Katrin Leitmeyer, European Center for Disease
Control, Maria Zambon, Public Health England, UK;
Christian Drosten, Charité - Universitätsmedizin
Berlin, Germany; Marion Koopmans, Erasmus MC,
Rotterdam, The Netherlands; Leo Poon, Hong Kong
University, China, Hong Kong SAR; George Gao,
Chinese CDC, China.
4)
5)
WHO: Karen Nahapetyan, Francis Inbanathan,
Dmitriy Pereyaslov, Christine Uhlenhaut, Varja
Grabovac, Katelijn Vandemaele, Magdi Samaan,
Christian Fuster, Wenqing Zhang, Lisa Stevens,
Chris Oxenford, Sebastian Cognat, Kazunobu
Kojima, Carmen Dolea, Caroline Brown, Céline
Barnadas, Maria Van Kerkhove, Lisa Carter, Mark
D Perkins and Karin von Eije
6)
8. References
7)
1) Na Zhu, Dingyu Zhang, Wenling Wang,
Xingwang Li, Bo Yang, Jingdong Song,
Xiang Zhao, Baoying Huang, Weifeng Shi,
Roujian Lu, Peihua Niu, Faxian Zhan,
Xuejun Ma, Dayan Wang, Wenbo Xu,
Guizhen Wu, George F. Gao, Wenjie Tan,
et al. A novel coronavirus from patients
with pneumonia in China, 2019, N Engl J
Med. 2020 Jan 24.
2) Severe acute respiratory syndrome-related
coronavirus: The species and its viruses – a
statement of the Coronavirus Study Group.
Alexander E. Gorbalenya, Susan C. Baker,
Ralph S. Baric, Raoul J. de Groot,
Christian Drosten, Anastasia A. Gulyaeva,
Bart L. Haagmans, Chris Lauber, Andrey
M Leontovich, Benjamin W. Neuman,
Dmitry Penzar, Stanley Perlman, Leo L.M.
Poon, Dmitry Samborskiy, Igor A. Sidorov,
Isabel Sola, John Ziebuhr. Severe acute
respiratory syndrome-related coronavirus:
The species and its viruses – a statement of
the Coronavirus Study Group. bioRxiv
2020.02.07.937862; doi:
https://doi.org/10.1101/2020.02.07.937862
3) Laboratory testing for Middle East
Respiratory Syndrome coronavirus, interim
guidance (revised), January 2019,
WHO/MERS/LAB/15.1/Rev1/2019, World
Health Organization, 2018.
(https://apps.who.int/iris/bitstream/handle/1
8)
9)
10)
11)
7
0665/259952/WHO-MERS-LAB-15.1-
Rev1-2018-
eng.pdf;jsessionid=08939A780A5A4552E
C8279D0E6D650E4?sequence=1)
Managing epidemics, key facts about major
deadly diseases. Geneva: World Health
Organization; 2018.
(https://apps.who.int/iris/handle/10665/272
442).
WHO Global Influenza Surveillance
Network Manual for the laboratory
diagnosis and virological surveillance of
influenza, WHO, 2011
(https://www.who.int/influenza/gisrs_labor
atory/manual_diagnosis_surveillance_influ
enza/en/).
Protocol to investigate non-seasonal
influenza and other emerging acute
respiratory diseases. Geneva: World Health
Organization; 2018.
(https://www.who.int/influenza/resources/p
ublications/outbreak_investigation_protoco
l/en/).
WHO Recommended Surveillance
Standards WHO/CDS/CSR/ISR/99.2
(https://www.who.int/csr/resources/publicat
ions/surveillance/whocdscsrisr992.pdf).
Guideline for the collection of clinical
specimens during field investigation of
outbreaks WHO/CDS/CSR/EDC/200.4
(https://www.who.int/ihr/publications/WH
O_CDS_CSR_EDC_2000_4/en/).
WHO laboratory biosafety manual, third
edition. Geneva: World Health
Organization; 2004.
(http://www.who.int/csr/resources/publicati
ons/biosafety/
WHO_CDS_CSR_LYO_2004_11/en/).
Global Surveillance for human infection
with coronavirus disease (COVID-2019),
Interim guidance, Geneva, World Health
Organization, 2020.
(https://www.who.int/publications-
detail/global-surveillance-for-human-
infection-with-novel-coronavirus-(2019-
ncov).
Qun Li, Xuhua Guan, Peng Wu, et al. Early
Transmission Dynamics in Wuhan, China,
of Novel Coronavirus–Infected Pneumonia.
N Eng Jour Med.
January 29, 2020.